
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
Details : This drug candidate is currently being evaluated in Approved FDF clinical studies for the treatment of Memory Disorders.
Product Name : MyndMed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
October 07, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Vitamin D,Calcium,Potassium
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
BioAdaptives, Inc. Commences Development of a New Supplement for Womens Health
Details : PluriPain-PMS, an advanced, all natural anti-inflammatory and mood-enhancing Women’s Health formula to combat specific symptoms associated with the menstrual cycle.
Product Name : PluriPain-PMS
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
October 05, 2023
Lead Product(s) : Vitamin D,Calcium,Potassium
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lutein,Astaxanthin
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Sponsor : LY Research Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : The agreement aims to market a patented product for Eye Health due to Myopia and Presbyopia. This Patent is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Undisclosed
March 30, 2023
Lead Product(s) : Lutein,Astaxanthin
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Sponsor : LY Research Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Phycocyanin,Boswellia Serata,Methylsulphonylmethane
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners
Details : PluriPain, is a safe, all-natural supplement formula to manage your aching joints, sore back and other pains.
Product Name : PluriPain
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 14, 2022
Lead Product(s) : Phycocyanin,Boswellia Serata,Methylsulphonylmethane
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Phycocyanin,Boswellia Serata,Methylsulphonylmethane
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Stanford Medical Center
Deal Size : Undisclosed
Deal Type : Collaboration
BioAdaptives Collaboration with Stanford Professor
Details : Dr. Koran’s of Stanford Medical Center will study BioAdaptives' natural supplement formulation, PluriPain®, for its pain-relieving, anti-inflammatory and antioxidant effects. BioAdaptives’ participation is limited to providing PluriPain® for Dr. Ko...
Product Name : PluriPain
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 26, 2021
Lead Product(s) : Phycocyanin,Boswellia Serata,Methylsulphonylmethane
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Stanford Medical Center
Deal Size : Undisclosed
Deal Type : Collaboration
